BIO-CAT Microbials, LLC has announced a $35 million investment to significantly expand its Troy, VA facility to include fermentation capabilities. The company said it will be breaking ground on an initial 53,800-square-foot expansion phase this month, with potential future expansion up to an additional 100,000 square feet. The expansion-anticipated to be completed in May of 2023-will allow BIO-CAT Microbials to continue to scale its high-tech microbial fermentation production by adding state-of-the-art fermentation manufacturing facilities, quality labs and a research and development center. It will also include custom-designed fermentation equipment that will allow for both small and large batch manufacturing. This expanded capacity will provide the potential for BIO-CAT Microbials to grow its current fermentation production by more than 400 percent. "This expansion will be a huge boon for our fermentation capabilities, allowing us to further scale our production to supply customers and partners, both old and new, with the best microbial products on the market," BIO-CAT CEO and Co-founder Chris Schuler said. "The plans we have in place will make our Troy facilities truly best-in-class. We're looking forward to breaking ground and getting started." BIO-CAT Microbials manufactures a dozen proprietary Bacillus microbial strains for the human probiotic, production and companion animal, and crop science markets. [...] The post BIO-CAT Microbials Invests $35 Million in State-of-the-Art Fermentation Facility appeared first on Nutrition Industry Executive Magazine.
